Pacira BioSciences Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Valuation Ratios
P/E Ratio37.34111.3563.8517.86
Forward P/E7.1010.2311.6315.4318.33
P/S Ratio1.242.322.664.956.05
P/B Ratio1.121.802.293.674.20
Price/Tangible Book2.477.0124.876.14
Price/FCF4.8711.2315.3833.5766.27
Price/OCF4.5910.1312.1921.3233.75
PEG Ratio0.600.600.530.660.59
Enterprise Value Ratios
EV/Revenue1.512.853.404.696.06
EV/EBITDA6.0111.8014.9021.4536.46
EV/EBIT10.8722.0131.9328.2650.55
EV/FCF5.9313.7819.6631.8266.37
Profitability & Returns
Return on Equity (ROE)-0.12%0.05%0.02%0.06%0.30%
Return on Assets (ROA)0.04%0.03%0.02%0.03%0.03%
Return on Invested Capital (ROIC)0.09%0.05%0.06%0.07%0.10%
Return on Capital Employed (ROCE)0.08%0.06%0.05%0.06%0.05%
Leverage & Solvency Ratios
Debt/Equity0.820.670.981.550.87
Debt/EBITDA3.333.284.558.546.47
Debt/FCF3.574.206.6314.1413.79
Liquidity Ratios
Current Ratio2.405.243.371.662.57
Quick Ratio1.933.952.631.452.27
Efficiency Ratios
Asset Turnover0.450.410.350.320.41
Inventory Turnover2.192.602.922.402.88
Yield & Distribution Ratios
Earnings Yield-0.11%0.03%0.01%0.02%0.06%
FCF Yield0.21%0.09%0.07%0.03%0.02%
Buyback Yield0.11%-0.12%-0.02%-0.04%-0.05%